Outset Medical (OM) Restructuring Costs (2024)
Outset Medical's (OM) quarterly Restructuring Costs came in at $1.5 million in Q4 2024, up 7.14% quarter-over-quarter from $1.4 million in Q3 2024.
Analysis
Outset Medical (OM) Restructuring Costs (2024) Analysis & Trends
Outset Medical (OM) has reported Restructuring Costs for 1 consecutive years, with $1.5 million the latest figure, recorded in Q4 2024.
- On a quarterly basis, Restructuring Costs changed N/A year-over-year to $1.5 million in Q4 2024; TTM through Dec 2024 was $5.6 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.5 million, down 40.0% from the prior year.
- Restructuring Costs was $1.5 million for Q4 2024 at Outset Medical, up from $1.4 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $2.7 million in Q1 2024 and troughed at $1.4 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Outset Medical | 59.77 Mn | -203.42 Mn | 13.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 2.70 Mn |